Adjunct ketamine treatment effects on treatment-resistant depressive symptoms in chronic treatment-resistant schizophrenia patients are short-term and disassociated from regional homogeneity changes in key brain regions – a pilot study
Sign Up to like & getrecommendations! Published in 2019 at "Psychiatry and Clinical Psychopharmacology"
DOI: 10.1080/24750573.2019.1699726
Abstract: ABSTRACT BACKGROUND: To investigate the effects of adjunct ketamine treatment on depressive symptoms and brain activity in chronic treatment-resistant schizophrenia (CTRS) patients with treatment-resistant depressive (TRD) symptoms. METHODS: Calgary Depression Scale for Schizophrenia (CDSS), positive… read more here.
Keywords: adjunct ketamine; treatment resistant; treatment; ctrs patients ... See more keywords